About Infinia Sciences Private Limited
Data last updated:
Infinia Sciences Private Limited is a private limited company based in Pune, Maharashtra, India, recognised as a startup by DPIIT. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 10 December 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24299PN2020PTC196732. Its GSTIN is 27AAFCI9385L1ZS (Maharashtra).
The company has an authorised share capital of ₹90 Lakh and a paid-up capital of ₹86.8 Lakh. It is led by directors including Prerana Sambhaji Patil and Surekha Vikram Chede.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Tower – E – 202 Eon Water Front S. No.70/3A/1 Pune City, Maharashtra, India – 411014.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.07 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹53.23 Lakh (net margin 6.6%) and EBITDA of ₹1.19 Cr (EBITDA margin 14.8%). Revenue has grown at a compounded annual rate (CAGR) of 144% over three years.
The company has about 20 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Infiniasciences. As per MCA filings, the company has open charges of ₹1 Cr and satisfied charges of ₹1.5 Cr on record.
For more details, the company can be reached via its website infiniasciences.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressTower – E – 202 Eon Water Front S. No.70/3A/1 Pune City, Maharashtra, India – 411014
- IndustryPharma, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Infinia Sciences Private Limited
The main business activity of Infinia Sciences is professional, scientific and technical. In detail, this covers scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Infinia Sciences Private Limited FY 2025 filings available
Infinia Sciences Private Limited reported revenue of ₹8.07 Cr (up 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Infinia Sciences Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 144% over three years, including 6% growth in the latest year. EBITDA rose 65% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Infinia Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.19 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹53.23 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Infinia Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 6.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Infinia Sciences are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Infinia Sciences Private Limited
Infinia Sciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Contract Research). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Chemiasoft Private Limited | ₹8.4 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Khairatabad, Telangana, India |
| Sensan Biosciences Private Limited | ₹8.28 Cr (FY 2025) | •••• | •••• | 149.0% | •••• | Chennai City Corporation, Tamil Nadu, India |
| Notrox Research Private Limited | ₹8.18 Cr (FY 2024) | •••• | •••• | -15.0% | •••• | Bangalore, Karnataka, India |
| Let's Evolve Life Private Limited | ₹8.12 Cr (FY 2024) | •••• | •••• | -25.0% | •••• | Mumbai, Maharashtra, India |
| Convallaer Pharmaceuticals Private Limited | ₹8.1 Cr (FY 2024) | •••• | •••• | 36.0% | •••• | Kanpur, Uttar Pradesh, India |
| Infinia Sciences Private Limited this company | ₹8.07 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Pune, Maharashtra, India |
| Quench Life Sciences Private Limited | ₹7.8 Cr (FY 2025) | •••• | •••• | 351.0% | •••• | Tirumalagiri, Telangana, India |
| Sphaera Pharma Private Limited | ₹7.73 Cr (FY 2024) | •••• | •••• | 6.0% | •••• | New Delhi, Delhi, India |
| Cddep India Private Limited | ₹7.69 Cr (FY 2025) | •••• | •••• | -65.0% | •••• | Chickballapur, Karnataka, India |
| Asphar Research Labs Private Limited | ₹7.57 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Hyderabad, Telangana, India |
| Obvez Labs Private Limited | ₹7.54 Cr (FY 2024) | •••• | •••• | 11.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Infinia Sciences by revenue in the Pharma industry (Contract Research), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Infinia Sciences Private Limited
Infinia Sciences Private Limited is audited by SBH & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SBH & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Infinia Sciences Private Limited
Infinia Sciences has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prerana Sambhaji Patil Also directs: Orbis Industrries Private Limited | Director | 01 Mar 2022 | 4 Years 7 Months | Current |
| Surekha Vikram Chede Also directs: Orbis Industrries Private Limited | Director | 10 Dec 2020 | 5 Years 9 Months | Current |
| Sanket Vikramrao Chede Also directs: Orbis Industrries Private Limited, Ashni Ventures Private Limited | Director | 10 Dec 2020 | 5 Years 9 Months | Current |
Ownership and Shareholding of Infinia Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Infinia Sciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Nov 2022 | Others | ₹1 Cr | Open |
| 11 May 2022 | Others | ₹1.5 Cr | Satisfied |
Total charge records: 2 View all charges
Associated Brands with Infinia Sciences Private Limited
Infinia Sciences operates one associated brand: Infiniasciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers contract research, synthesis, and manufacturing for pharmaceuticals and agrochemicals globally. | infiniasciences.com |
Employees and EPFO Compliance at Infinia Sciences Private Limited
Infinia Sciences Private Limited has a workforce of 20 employees as of Apr 09, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Infinia Sciences Private Limited
Infinia Sciences Private Limited has 9 board changes on record since 2020: 6 appointments and 3 cessations. The latest: Petal Suhas Gangurde ceased to be Director on 01 Jan 2025.
3 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Infinia Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Infinia Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Infinia Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Infinia Sciences Private Limited
Infinia Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCI9385L1ZS | Maharashtra | Active | 08 Jan 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Infinia Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Infinia Sciences Private Limited
Infinia Sciences is an active private limited company based in Pune, Maharashtra, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 10 December 2020 (6+ years old) and is registered under CIN U24299PN2020PTC196732.
Infinia Sciences reported revenue of ₹8.07 Cr for FY 2025 (up 6% YoY).
Infinia Sciences has 3 current directors:
- Prerana Sambhaji Patil - Director
- Surekha Vikram Chede - Director
- Sanket Vikramrao Chede - Director
Infinia Sciences reported a net profit of ₹53.23 Lakh (net margin 6.6%) and EBITDA of ₹1.19 Cr (EBITDA margin 14.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Infinia Sciences is 144% over three years. In the latest year (FY 2025) revenue rose 6%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Infinia Sciences is 27AAFCI9385L1ZS, registered in Maharashtra.
The CIN (Corporate Identification Number) of Infinia Sciences is U24299PN2020PTC196732. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Infinia Sciences was incorporated on 10 December 2020, making it 6+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Infinia Sciences by revenue are Chemiasoft Private Limited, Sensan Biosciences Private Limited, Notrox Research Private Limited, Let's Evolve Life Private Limited, Convallaer Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Contract Research).
Petal Suhas Gangurde ceased to be Director on 01 Jan 2025. Snehank Vikram Chede ceased to be Director on 01 Jan 2025. Prerana Sambhaji Patil was appointed as Director on 01 Mar 2022. Infinia Sciences has 9 board changes on record in total.
Yes, Infinia Sciences is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).